Lindbrook Capital’s Xperi XPER Stock Holding History

Lindbrook Capital’s Portfolio XPER Stock Details XPER Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-39	Closed	-$426	–	2864
2023 Q1	$426	Buy	+39	New	+$406	﹤0.01%	2634

Other funds holding XPER

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $128B AUM 35.83% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Clearline Capital New York $1.68B AUM 53.07% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Lindbrook Capital's XPER Position: Q2 2023 in Review

Lindbrook Capital sold out of Xperi (XPER) in Q2 2023, closing a stake of 39 shares — an estimated $426 sold.

Lindbrook Capital first reported a position in XPER in Q1 2023 and held it in 1 quarter. The position peaked at $426 in Q1 2023. 160 funds tracked by Wall St. Rank hold XPER as of Q2 2023.

Lindbrook Capital reported no remaining Xperi position as of Q2 2023 after selling out during the quarter.
Lindbrook Capital sold 39 Xperi shares in Q2 2023, an estimated $426.
Lindbrook Capital first reported a position in Xperi in Q1 2023 and held it in 1 quarter.
Lindbrook Capital's Xperi position peaked at $426 in Q1 2023.
160 funds tracked by Wall St. Rank held Xperi as of Q2 2023.

Based on Lindbrook Capital's 13F filing for Q2 2023, filed 31 Jul 2023.